REGN•benzinga•
Regeneron Pharmaceuticals And Sanofi Announce FDA Approval of Dupixent For Chronic Spontaneous Urticaria in Adults and Adolescents
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 18, 2025 by benzinga